Usfda Issues 1 Observation For Granules Pharma Usa Facility
USFDA issues 1 observation for Granules Pharma USA facility
USFDA issues 1 observation for Aurobindo Pharma arm AP facility
USFDA issues one observation for Natco Pharma Mekaguda unit
USFDA issues 2 observations for Granules India's US arm facility ...
SMS Pharma gets one USFDA observation for Bachupally facility
Gland Pharma gets one 483 Observation from USFDA for Dundigal facility
USFDA inspection: At Granules India arm with 1 observation
Granules Gagillapur Plant: USFDA issues EIR for Granules India's ...
Granules Pharma facility gets 5 USFDA observations
USFDA issues one observation to Aurobindo Pharma subsidiary’s plant ...
Advertisement Space (300x250)
Granules Pharmaceuticals Receives USFDA EIR for Chantilly Facility with ...
Granules India Resolves USFDA Observation at Virginia Facility
Granules India Ltd: Granules India Receives USFDA Observation for ...
Granules India Secures USFDA EIR for Chantilly Facility Following 4 ...
Granules Life Sciences gets USFDA approval for Hyderabad Facility
USFDA issues 3 observations to Alembic Pharma for Gujarat plant ...
Granules India shares fall after USFDA issues one observation to ...
Granules Pharma gets USFDA nod for Potassium Chloride for Oral Solution
USFDA issued Form 483 to Alembic Pharma with 1 observation
USFDA issues OAI Classification after inspection to Granules India
Advertisement Space (336x280)
Granules India US FDA Issues Establishment Inspection Report for US ...
USFDA completes inspection at facility of Granules India’s arm ...
USFDA issues Warning Letter to Granules India over these Deficiencies
USFDA issues Form 483 with five observations to Torrent Pharma unit, ET ...
Ajanta Pharma USFDA Inspection: USFDA issues Form-483 with 5 ...
US FDA issues warning letter to Intas Pharma for manufact...
Granules Pharma Gets US FDA Tentative Approval for Generic ADZENYS XR ...
Granules Life Sciences’ facility gets VAI classification from USFDA ...
Granules Pharma Amphetamine Mixed Salts gets USFDA okay to treat ADHD ...
U.S. FDA issues VAI classification to Granules arm Virginia facility ...
Advertisement Space (336x280)
USFDA issues form-483 with three observations to Granules India's ...
Gland Pharma's Hyderabad unit gets one observation from USFDA after ...
USFDA Pharma Compliance and Inspection Readiness Guide - Laafon Galaxy ...
Understanding FDA Observations: A Guide for Pharma Professionals
Understanding FDA Observations: A Guide for Pharma Professionals - YouTube
Alkem’s Enzene Unit Gets USFDA Form 483: 6 Observations, No Data Issues